Daniel Rueda

3.2k citations

49 papers · 2.0k indexed · h-index 18

Impact in

Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior

Papers in ⓘ

Pathology and Forensic Medicine 23
- Genetic factors in colorectal cancer 22
Cancer Research 15
- Cancer Genomics and Diagnostics 14

Co-authors: Ismael Galve‐Roperh (10 shared papers)Manuel Guzmán (10 shared papers)Cristina Sánchez (4 shared papers)Guillermo Velasco (3 shared papers)Teresa Gómez del Pulgar (2 shared papers)Amador Haro (2 shared papers)Beatriz Navarro (1 shared paper)Alberto Martínez‐Serrano (1 shared paper)
Journals: Molecular Pharmacology (6 papers)Scientific Reports (2 papers)Oncotarget (2 papers)British Journal of Cancer (2 papers)Journal of Molecular Diagnostics (2 papers)
Partner nations: Spain United States Italy

In The Last Decade

Daniel Rueda

47 papers receiving 2.0k citations

Peers

Countries citing papers authored by Daniel Rueda

Since Specialization

Citations

This map shows the geographic impact of Daniel Rueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Rueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Rueda more than expected).

Fields of papers citing papers by Daniel Rueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Rueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Rueda. The network helps show where Daniel Rueda may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel Rueda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel Rueda Line = papers co-authored together Daniel Rueda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Research ·Cristina Sánchez, Marı́a L. de Ceballos, Teresa Gómez del Pulgar, Daniel Rueda, C. Corbacho, Guillermo Velasco, Ismael Galve‐Roperh, John W. Huffman, Santiago Ramón y Cajal, Manuel Guzmán	2001	360
2	The proteolytic activity of the paracaspase MALT1 is key in T cell activation Nature Immunology ·Fabien Rebeaud, Stephan Hailfinger, Anita Posevitz‐Fejfár, Myriam Tapernoux, Roger Moser, Daniel Rueda, Olivier Gaide, Montserrat Guzzardi, Emanuela M. Iancu, Nathalie Rufer, Nicolás Fasel, Margot Thome	2008	237
3	The Endocannabinoid Anandamide Inhibits Neuronal Progenitor Cell Differentiation through Attenuation of the Rap1/B-Raf/ERK Pathway Journal of Biological Chemistry ·Daniel Rueda, Beatriz Navarro, Alberto Martínez‐Serrano, Manuel Guzmán, Ismael Galve‐Roperh	2002	200
4	The CB₁Cannabinoid Receptor Is Coupled to the Activation of c-Jun N-Terminal Kinase Molecular Pharmacology ·Daniel Rueda, Ismael Galve‐Roperh, Amador Haro, Manuel Guzmán	2000	160
5	Involvement of Sphingomyelin Hydrolysis and the Mitogen-Activated Protein Kinase Cascade in the Δ9-Tetrahydrocannabinol-Induced Stimulation of Glucose Metabolism in Primary Astrocytes Molecular Pharmacology ·Cristina Sánchez, Ismael Galve‐Roperh, Daniel Rueda, Manuel Guzmán	1998	156
6	Mechanism of Extracellular Signal-Regulated Kinase Activation by the CB1 Cannabinoid Receptor Molecular Pharmacology ·Ismael Galve‐Roperh, Daniel Rueda, Teresa Gómez del Pulgar, Guillermo Velasco, Manuel Guzmán	2002	155
7	Involvement of the cAMP/protein kinase A pathway and of mitogen‐activated protein kinase in the anti‐proliferative effects of anandamide in human breast cancer cells FEBS Letters ·Dominique Melck, Daniel Rueda, Ismael Galve‐Roperh, Luciano De Petrocellis, Manuel Guzmán, Vincenzo Di Marzo	1999	142
8	The CB₁ Cannabinoid Receptor of Astrocytes Is Coupled to Sphingomyelin Hydrolysis through the Adaptor Protein Fan Molecular Pharmacology ·Cristina Sánchez, Daniel Rueda, Bruno Ségui, Ismael Galve‐Roperh, Thierry Levade, Manuel Guzmán	2001	76
9	Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development Current Pharmaceutical Design ·Ismael Galve‐Roperh, Tania Aguado, Daniel Rueda, Guillermo Velasco, Manuel Guzmán	2006	74
10	Age at Onset Should Be a Major Criterion for Subclassification of Colorectal Cancer Journal of Molecular Diagnostics ·José Perea, Daniel Rueda, Alicia Canal, Yolanda Rodríguez, Edurne Álvaro, Irene Osorio, C. Alegre, Bárbara Rivera, Joaquín Martínez‐López, Javier Benı́tez, Miguel Urioste	2013	64
11	Bcl10 Controls TCR- and FcγR-Induced Actin Polymerization The Journal of Immunology ·Daniel Rueda, Olivier Gaide, Liza Ho, Elodie Lewkowicz, Florence Niedergang, Stephan Hailfinger, Fabien Rebeaud, Montserrat Guzzardi, Béatrice Conne, Marcus Thelen, Jérôme Delon, Uta Ferch, Tak W. Mak, Jürgen Ruland, Juerg Schwaller, Margot Thome	2007	39
12	DNA copy number profiling reveals different patterns of chromosomal instability within colorectal cancer according to the age of onset Molecular Carcinogenesis ·María Arriba, Juan Luis Garcı́a, Lucía Inglada‐Pérez, Daniel Rueda, Irene Osorio, Yolanda Rodríguez, Edurne Álvaro, R Maruri Sanchez, Tamara Fernández, Jessica Pérez, Jesús María Hernández‐Rivas, Javier Benı́tez, Rogelio González‐Sarmiento, Miguel Urioste, José Perea	2015	26
13	Clinical and Molecular Comparative Study of Colorectal Cancer Based on Age-of-Onset and Tumor Location: Two Main Criteria for Subclassifying Colorectal Cancer International Journal of Molecular Sciences ·Edurne Álvaro, Juana María Cano, Juan Luis Garcı́a, Lorena Brandáriz, Susana Olmedillas‐López, María Arriba, Daniel Rueda, Yolanda Rodríguez, Ángel Cañete, Julia Arribas, Lucía Inglada‐Pérez, Jessica Pérez, Carlos Martín, Mariano García‐Arranz, Damián García‐Olmo, Ajay Goel, Miguel Urioste, Rogelio González‐Sarmiento, José Perea	2019	24
14	Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers Scientific Reports ·Sandra Tapial, Susana Olmedillas‐López, Daniel Rueda, María Arriba, Juan Luis Garcı́a, Alfredo Vivas López, Jessica Pérez, Laura Pena-Couso, Rocío Olivera-Salazar, Yolanda Rodríguez, Mariano García‐Arranz, Damián García‐Olmo, Rogelio González‐Sarmiento, Miguel Urioste, Ajay Goel, José Perea	2019	20
15	Early-Onset Colorectal Cancer is an Easy and Effective Tool to Identify Retrospectively Lynch Syndrome Annals of Surgical Oncology ·José Perea, Yolanda Rodríguez, Daniel Rueda, José Carlos Marín-Gabriel, José Díaz-Tasende, Edurne Álvaro, C. Alegre, Irene Osorio, Francisco Colina, Manuel Lomas, Manuel Hidalgo, Javier Benı́tez, Miguel Urioste	2011	20
16	Primary constitutional MLH1 epimutations: a focal epigenetic event British Journal of Cancer ·Estela Dámaso, Adela Castillejo, María del Mar Arias, Júlia Canet-Hermida, Matilde Navarro, Jesús Del Valle, Olga Campos, Anna Fernández, Fátima Marín, Daniela Turchetti, García Díaz, Conxi Lázaro, Maurizio Genuardi, Daniel Rueda, Ángel Alonso, José Luís Soto, Megan P. Hitchins, Marta Pineda, Gabriel Capellá	2018	19
17	Inhibition of relatedJAK/STATpathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm British Journal of Haematology ·Santiago Barrio, Miguel Gallardo, Alicia Arenas, Rosa Ayala, Inmaculada Rapado, Daniel Rueda, Ana Jiménez Ubieto, Enriqueta Albízua, Carmen Burgaleta, Florinda Gilsanz, Joaquín Martínez‐López	2013	19
18	Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X Journal of Gastroenterology ·E. Sánchez-Tomé, Bárbara Rivera, José Perea, Guillermo Pita, Daniel Rueda, Fátima Mercadillo, Alicia Canal, Anna González‐Neira, Javier Benı́tez, Miguel Urioste	2014	17
19	A Collaborative Effort to Define Classification Criteria forATMVariants in Hereditary Cancer Patients Clinical Chemistry ·Lídia Feliubadaló, Alejandro Moles‐Fernández, Marta Santamariña, Alysson T Sánchez, Anael López‐Novo, Luz-Marina Porras, Ana Blanco, Gabriel Capellá, Miguel de la Hoya, Ignacio J. Molina, Ana Osório, Marta Pineda, Daniel Rueda, Xavier de la Cruz, Orland Dı́ez, Clara Ruíz-Ponte, Sara Gutiérrez‐Enríquez, Ana Vega, Conxi Lázaro	2020	15
20	Classifying early-onset colorectal cancer according to tumor location: new potential subcategories to explore. PubMed ·José Perea, Juana María Cano, Daniel Rueda, Juan Luis Garcı́a, Lucía Inglada‐Pérez, Irene Osorio, María Arriba, Jessica Pérez, Miriam Gaspar, Tamara Fernández-Miguel, Yolanda Rodríguez, Javier Benı́tez, Rogelio González‐Sarmiento, Miguel Urioste	2015	14

About Daniel Rueda

Daniel Rueda is a scholar working on Pathology and Forensic Medicine, Cancer Research, Oncology, Pharmacology and Cellular and Molecular Neuroscience, having authored 49 papers that have together received 2.0k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (22 papers), Cancer Genomics and Diagnostics (14 papers), Colorectal Cancer Screening and Detection (12 papers), Cannabis and Cannabinoid Research (10 papers), Colorectal Cancer Treatments and Studies (7 papers), Neuroscience and Neuropharmacology Research (6 papers), Pancreatic function and diabetes (5 papers) and Sleep and Wakefulness Research (5 papers). The work is most often cited by research in Pharmacology (1.1k citations), Cellular and Molecular Neuroscience (726 citations), Cancer Research (299 citations), Pathology and Forensic Medicine (319 citations) and Toxicology (53 citations). Daniel Rueda has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Ismael Galve‐Roperh, Manuel Guzmán, Cristina Sánchez, Guillermo Velasco, Teresa Gómez del Pulgar, Amador Haro, Beatriz Navarro, Alberto Martínez‐Serrano, Santiago Ramón y Cajal and Marı́a L. de Ceballos. Their work appears in journals such as Molecular Pharmacology, Scientific Reports, Oncotarget, British Journal of Cancer and Journal of Molecular Diagnostics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact